Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The Lancet. Oncology|February 11, 2019
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trialMatthew Smith, Chris Parker, Fred Saad, et al.
JAMA Oncology|October 26, 2023
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical TrialStéphane Oudard, Raffaele Ratta, Eric Voog, et al.
The Journal of Urology|July 3, 2017
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial CarcinomaLaura-Maria Krabbe, Barbara Heitplatz, Sina Preuss, et al.
European Urology Oncology|August 14, 2024
Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY TrialStephane Oudard, Yohann Tran, Carole Helissey, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2026
Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological reviewMarit Ahrens, John Haanen, Laurence Albiges, et al.
Pageof 6